DPH.L - Dechra Pharmaceuticals plc

LSE - LSE Delayed price. Currency in GBp
2,720.00
-24.00 (-0.87%)
At close: 4:37PM BST
Stock chart is not supported by your current browser
Previous close2,744.00
Open2,750.00
Bid0.00 x 34700
Ask0.00 x 29800
Day's range2,720.00 - 2,772.00
52-week range1,636.00 - 2,840.00
Volume257,282
Avg. volume346,014
Market cap2.782B
Beta0.52
PE ratio (TTM)59.13
EPS (TTM)46.00
Earnings date20 Feb 2017 - 24 Feb 2017
Forward dividend & yield0.23 (0.81%)
Ex-dividend date2018-03-08
1y target est2,595.29
  • PR Newswire3 months ago

    Veterinary Group Dechra - 2018 Interim Results

    Dechra Pharmaceuticals PLC, LSE: Main Market: symbol DPH) today releases its Half-Yearly Financial Report 2018 for the six months ended 31 December 2017 (the Period). "Dechra has performed well in the Period with solid revenue growth in EU pharmaceuticals and strong revenue growth in NA Pharmaceuticals from the existing business. Current trading continues in line with management expectations and the initial phase of integration of the AST Farma/Le Vet acquisition is progressing well.

  • Reuters4 months ago

    Dechra to buy Dutch firms AST Farma, Le Vet for 340 million euros

    (Reuters) - Veterinary firm Dechra Pharmaceuticals Plc (DPH.L) said it would buy the Netherlands-based AST Farma and Europe-focused Le Vet for 340 million euros (296.79 million pounds) in a cash and share ...

  • We're sorry this is all we were able to find about this topic.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes